Vietnam announces commercialization of ASF vaccine

125

Vietnam announced on June 1 that it has approved the commercialization of the ASF vaccine developed by the National Veterinary JSC (Navetco). The vaccine, Navet-ASFVac, has an 80% protective effectiveness against the virus, and will be priced at USD 1.50/dose. “With immunity lasting six months, the ...

Sign in  as a member, or Join our Community  for free to unlock the full article.

Ha Thu
Correspondent based in Ho Chi Minh City, Vietnam.